metoclopramide has been researched along with Adenoma, Prostatic in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baranowska, B | 1 |
| Jeske, W | 1 |
| Szymanowski, J | 1 |
| Piechna, K | 1 |
1 other study available for metoclopramide and Adenoma, Prostatic
| Article | Year |
|---|---|
[Increased secretion of prolactin after inhibition of dopaminergic receptors by metoclopramide in patients with cancer of the prostate].
Topics: Adult; Aged; Humans; Male; Metoclopramide; Middle Aged; Prolactin; Prostatic Hyperplasia; Prostatic | 1983 |